Mela Sciences seeks reimbursement for melanoma detector

Mela Sciences hopes to have Medicare reimbursement for its MelaFind skin lesion analysis as early as January 2016.

Centers for Medicare and Medicaid Services (CMS), MELA Sciences Inc.

News Well, Diagnostics, Medicare, Oncology, Reimbursement

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1w6seGs